These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing. Pautrat A; Rolland M; Barthelemy M; Baunez C; Sinniger V; Piallat B; Savasta M; Overton PG; David O; Coizet V Elife; 2018 Aug; 7():. PubMed ID: 30149836 [TBL] [Abstract][Full Text] [Related]
65. How does environmental enrichment reduce repetitive motor behaviors? Neuronal activation and dendritic morphology in the indirect basal ganglia pathway of a mouse model. Bechard AR; Cacodcar N; King MA; Lewis MH Behav Brain Res; 2016 Feb; 299():122-31. PubMed ID: 26620495 [TBL] [Abstract][Full Text] [Related]
66. In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington's Disease Mouse Model. Steventon JJ; Harrison DJ; Trueman RC; Rosser AE; Jones DK; Brooks SP J Huntingtons Dis; 2015; 4(2):149-60. PubMed ID: 26397896 [TBL] [Abstract][Full Text] [Related]
67. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. Walker AG; Miller BR; Fritsch JN; Barton SJ; Rebec GV J Neurosci; 2008 Sep; 28(36):8973-82. PubMed ID: 18768691 [TBL] [Abstract][Full Text] [Related]
68. Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line. Brooks SP; Jones L; Dunnett SB Brain Res Bull; 2012 Jun; 88(2-3):130-6. PubMed ID: 21763407 [TBL] [Abstract][Full Text] [Related]
69. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Southwell AL; Franciosi S; Villanueva EB; Xie Y; Winter LA; Veeraraghavan J; Jonason A; Felczak B; Zhang W; Kovalik V; Waltl S; Hall G; Pouladi MA; Smith ES; Bowers WJ; Zauderer M; Hayden MR Neurobiol Dis; 2015 Apr; 76():46-56. PubMed ID: 25662335 [TBL] [Abstract][Full Text] [Related]
70. Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease. Kuljis DA; Gad L; Loh DH; MacDowell Kaswan Z; Hitchcock ON; Ghiani CA; Colwell CS PLoS One; 2016; 11(2):e0147583. PubMed ID: 26871695 [TBL] [Abstract][Full Text] [Related]
71. Maladaptive Downregulation of Autonomous Subthalamic Nucleus Activity following the Loss of Midbrain Dopamine Neurons. McIver EL; Atherton JF; Chu HY; Cosgrove KE; Kondapalli J; Wokosin D; Surmeier DJ; Bevan MD Cell Rep; 2019 Jul; 28(4):992-1002.e4. PubMed ID: 31340159 [TBL] [Abstract][Full Text] [Related]
72. Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model. Koch ET; Sepers MD; Cheng J; Raymond LA Mov Disord; 2022 Oct; 37(10):2021-2032. PubMed ID: 35880748 [TBL] [Abstract][Full Text] [Related]
73. Interactions between cortical rhythms and spiking activity of single basal ganglia neurons in the normal and parkinsonian state. Gatev P; Wichmann T Cereb Cortex; 2009 Jun; 19(6):1330-44. PubMed ID: 18842667 [TBL] [Abstract][Full Text] [Related]
74. Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease. Zlebnik NE; Gildish I; Sesia T; Fitoussi A; Cole EA; Carson BP; Cachope R; Cheer JF Cereb Cortex; 2019 Dec; 29(11):4763-4774. PubMed ID: 30753343 [TBL] [Abstract][Full Text] [Related]
75. Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease. Lawhorn C; Smith DM; Brown LL Neurobiol Dis; 2008 Dec; 32(3):471-8. PubMed ID: 18809498 [TBL] [Abstract][Full Text] [Related]
76. Distinct cortico-striatal connections with subthalamic nucleus underlie facets of compulsivity. Morris LS; Baek K; Voon V Cortex; 2017 Mar; 88():143-150. PubMed ID: 28103527 [TBL] [Abstract][Full Text] [Related]
77. Biophysical and Architectural Mechanisms of Subthalamic Theta under Response Conflict. Moolchand P; Jones SR; Frank MJ J Neurosci; 2022 Jun; 42(22):4470-4487. PubMed ID: 35477903 [TBL] [Abstract][Full Text] [Related]
78. Hyperdirect connectivity of opercular speech network to the subthalamic nucleus. Jorge A; Lipski WJ; Wang D; Crammond DJ; Turner RS; Richardson RM Cell Rep; 2022 Mar; 38(10):110477. PubMed ID: 35263607 [TBL] [Abstract][Full Text] [Related]
79. Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone. Egorova PA; Gavrilova AV; Bezprozvanny IB Front Neurosci; 2020; 14():279. PubMed ID: 32317916 [TBL] [Abstract][Full Text] [Related]